Financials • Specialty Insurers
$197.03 ▲ +4.73
(+2.46%)
MKT CAP: $93.69B • VOL: 2.42M
52W L $157 52W H $203
MRSH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $26.98B | $24.46B | $22.74B |
| YoY Revenue Growth % | +10.3% | +7.6% | — |
| Gross Profit | $11.87B | $10.76B | $10.00B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $6.22B | $5.82B | $5.28B |
| Operating Margin % | 23.1% | 23.8% | 23.2% |
| Net Income (GAAP) | $4.16B | $4.06B | $3.76B |
| EBITDA (Normalized) | $6.46B | $6.07B | $6.10B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $5.29B | $4.30B | $4.26B |
| Capital Expenditures (CapEx) | $291.0M | $316.0M | $1.02B |
| Free Cash Flow (FCF) | $5.00B | $3.99B | $3.23B |
| FCF Margin % | 18.5% | 16.3% | 14.2% |
| Return on Invested Capital (ROIC %) | 11.2% | 10.4% | 13.4% |
| Cash & Short-Term Equivalents | $2.69B | $2.40B | $5.67B |
| Total Debt (Short + Long Term) | $18.32B | $19.43B | $12.06B |
| Total Stockholders' Equity | $28.18B | $27.11B | $24.73B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR MRSH.